1. Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?
    O. S. Ademowo et al, 2017, Biogerontology CrossRef
  2. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
    Bárbara González-Fernández et al, 2017, Front. Pharmacol. CrossRef
  3. The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: recent findings and new perspectives
    Andrea Huwiler et al, 2017, Pharmacology & Therapeutics CrossRef
  4. Sphingosine 1-Phosphate and Atherosclerosis.
    Makoto Kurano et al, 2018, J Atheroscler Thromb CrossRef
  5. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming
    Olga Sukocheva, 2018, IJMS CrossRef
  6. Lipid phosphate phosphatase 3 in vascular pathophysiology.
    Marco Busnelli et al, 2018, Atherosclerosis CrossRef
  7. Abnormal islet sphingolipid metabolism in type 1 diabetes
    Laurits J. Holm et al, 2018, Diabetologia CrossRef
  8. Yeast membrane lipid imbalance leads to trafficking defects toward the Golgi
    Sara Woodman et al, 2018, Cell Biol Int CrossRef
  9. Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
    Elin Rebecka Carlsson et al, 2018, Front. Endocrinol. CrossRef
  10. The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
    Nathan Wong et al, 2018, IJMS CrossRef
  11. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity
    Makoto Kurano et al, 2018, Biochem. J. CrossRef
  12. High glucose stimulates proliferative capacity of liver cancer cells possibly via O -GlcNAcylation-dependent transcriptional regulation of GJC1
    Yan Chen et al, 2018, J Cell Physiol CrossRef
  13. Inhibition of SphK2 Stimulated Hepatic Gluconeogenesis Associated with Dephosphorylation and Deacetylation of STAT3
    Jihong Yuan et al, 2018, Archives of Medical Research CrossRef
  14. Analysis of sphingolipid composition in human vitreous from control and diabetic individuals
    Lynda A. Wilmott et al, 2018, Journal of Diabetes and its Complications CrossRef
  15. Emergence of membrane sphingolipids as a potential therapeutic target
    Sunil Kumar Sahu et al, 2019, Biochimie CrossRef
  16. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases
    Eric Kwong et al, 2019, Liver Research CrossRef
  17. Effect of Sphingosine-1-Phosphate on Intracellular Free Ca2+ in Cat Esophageal Smooth Muscle Cells
    Dong Kyu Lee et al, 2018, Biomolecules & Therapeutics CrossRef
  18. Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism
    Eric K. Kwong et al, 2017, Curr Pharmacol Rep CrossRef
  19. Roles of sphingosine-1-phosphate signaling in cancer
    Peng Wang et al, 2019, Cancer Cell Int CrossRef
  20. Investigation of guanidinium chloride-induced unfolding pathway of sphingosine kinase 1
    Preeti Gupta et al, 2020, International Journal of Biological Macromolecules CrossRef
  21. Sphingosine kinase 1 mediates diabetic renal fibrosis via NF-κB signaling pathway: involvement of CK2α
    Junying Huang et al, 2017, Oncotarget CrossRef
  22. Whole transcriptome expression profiles in placenta samples from women with gestational diabetes mellitus
    Lei Tang et al, 2020, J Diabetes Investig CrossRef
  23. Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
    Deeba Shamim Jairajpuri et al, 2020, ACS Omega CrossRef
  24. Sphingosine‑1‑phosphate induces islet β‑cell proliferation and decreases cell apoptosis in high‑fat diet/streptozotocin diabetic mice
    Yizhi He et al, 2019, Exp Ther Med CrossRef
  25. Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes
    Jeanne Guitton et al, 2020, Cells CrossRef
  26. null
    Xian-Cheng Jiang, 2020 CrossRef
  27. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
    Patrycja Bielawiec et al, 2020, Biomolecules CrossRef
  28. Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice
    Byambasuren Ganbaatar et al, 2020, JAT CrossRef
  29. Role of ceramides in the pathogenesis of diabetes mellitus and its complications
    Nawajes Mandal et al, 2020, Journal of Diabetes and its Complications CrossRef
  30. K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice
    Jing Xie et al, 2020, Sci Rep CrossRef
  31. null
    Preeti Gupta et al, 2020 CrossRef
  32. Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial
    Luc Bergougnan et al, 2020, Br J Clin Pharmacol CrossRef
  33. Higher serum levels of autotaxin and phosphatidylserine‐specific phospholipase A 1 in patients with lupus nephritis
    Yasunori Iwata et al, 2020, Int J Rheum Dis CrossRef
  34. Trends in the Use of Sphingosine 1 Phosphate in Age-Related Diseases: A Scientometric Research Study (1992-2020)
    Qiong He et al, 2021, Journal of Diabetes Research CrossRef
  35. Neutral sphingomyelinase‐2 and cardiometabolic diseases
    Sardar Sindhu et al, 2021, Obesity Reviews CrossRef
  36. Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment
    Marie‐Claude Brulhart‐Meynet et al, 2021, Physiol Rep CrossRef
  37. Sphingosine 1-phosphate Stimulates Insulin Secretion and Improves Cell Survival by Blocking Voltage-dependent K+ Channels in β Cells
    Zhihong Liu et al, 2021, Front. Pharmacol. CrossRef
  38. Phospholipid Levels at Seroconversion Are Associated With Resolution of Persistent Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young
    Patrick M. Carry et al, 2021, Diabetes CrossRef
  39. Role of sphingosine kinase and sphingosine-1-phosphate receptor in the liver pathology of mice infected with Plasmodium berghei ANKA
    Tachpon Techarang et al, 2022, PLoS ONE CrossRef
  40. The role of sphingosine-1-phosphate in bone remodeling and osteoporosis
    Justus M. Grewe et al, 2022, Bone Res CrossRef